SCHEMBL4276429

SCHEMBL4276429

Oc1cccc2n[c]cnc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.50
ALDH1A1 P00352 3/20 0.45
MAPT P10636 2/20 0.45
RAB9A P51151 2/20 0.45
GAA P10253 1/20 0.45
KMT2A Q03164 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
TSHR P16473 2/20 0.41
METAP2 P50579 2/20 0.41
MMP2 P08253 2/20 0.41
CHRM1 P11229 1/20 0.41
COMT P21964 1/20 0.41
ADRA1A P35348 1/20 0.41
METAP1 P53582 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
NQO2 P16083 2/20 0.39
CYP1A2 P05177 2/20 0.38
KDM4E B2RXH2 7/20 0.35
ALOX12 P18054 3/20 0.35
LMNA P02545 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4273339 0.83 ACHE (0.50) ACHEALDH1A1MAPTRAB9AGAA
SCHEMBL7038180 0.78 PARP1 (0.33) ACHEALDH1A1MAPTRAB9AGAA
SCHEMBL35643 0.78 ELANE (0.33) ALDH1A1MAPTRAB9AKMT2AADRA1A
SCHEMBL17334525 0.78 GRM2 (0.33) ACHENQO2LMNAPDPK1
SCHEMBL2438399 0.76 ALDH1A1 (0.50) ALDH1A1MAPTRAB9ANPSR1TSHR
SCHEMBL7042564 0.75 NQO2 (0.50) ALDH1A1MAPTRAB9AKMT2AADRA1A
SCHEMBL276921 0.71 ACHE (0.56) ACHEALDH1A1MAPTRAB9AGAA
SCHEMBL11206718 0.71 ACHE (0.61) ACHEALDH1A1MAPTRAB9AGAA
SCHEMBL1973 0.70 MAPT (0.36) ACHEALDH1A1MAPTGAATSHR
SCHEMBL8510518 0.70 ACHE (0.54) ACHEALDH1A1MAPTRAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534793-B2 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity SMITHKLINE BEECHAM P.L.C. (GB) 2009-05-19 US claimed
EP-1305308-B1 AMINOPIPERIDINE QUINOLINES AND THEIR AZAISOSTERIC ANALOGUES WITH ANTIBACTERIAL ACTIVITY SMITHKLINE BEECHAM PLC (GB) 2006-12-20 EP claimed
US-7534793-B2 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity SMITHKLINE BEECHAM P.L.C. (GB) 2009-05-19 US disclosed
EP-1305308-B1 AMINOPIPERIDINE QUINOLINES AND THEIR AZAISOSTERIC ANALOGUES WITH ANTIBACTERIAL ACTIVITY SMITHKLINE BEECHAM PLC (GB) 2006-12-20 EP disclosed
US-20060014749-A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity SMITHKLINE BEECHAM P.L.C. 2006-01-19 US disclosed
US-6962917-B2 Aminopiperidine quinolines and their azaisosteric analogues with antibacterical activity SMITHKLINE BEECHAM P.L.C. (GB) 2005-11-08 US disclosed
EP-1305308-A1 AMINOPIPERIDINE QUINOLINES AND THEIR AZAISOSTERIC ANALOGUES WITH ANTIBACTERIAL ACTIVITY SMITHKLINE BEECHAM PLC (GB) 2003-05-02 EP disclosed
WO-2002008224-A1 AMINOPIPERIDINE QUINOLINES AND THEIR AZAISOSTERIC ANALOGUES WITH ANTIBACTERIAL ACTIVITY SMITHKLINE BEECHAM P.L.C. (GB) 2002-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060014749-A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity AZI2, NPEPPS, AMPD2 ACHE 1015/4885ALDH1A1 1016/4885MAPT 4441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.